Veristat managing new clinical trial
Courtesy Business Wire
Southborough-based Veristat, a clinical research organization, is overseeing a new immunotherapy clinical trial for patients with ovarian cancer, according to biopharmaceutical company OncoQuest Inc.
The announcement came Wednesday as OncoQuest enrolled the first patient in the trial, which will evaluate the use of the antibody oregovomab in combination with the investigational immunotherapy Hiltonol in patients with recurrent ovarian cancer, the company said.
The clinical trial is being conducted at Florida Hospital Cancer Institute in Orlando.
Veristat offers clinical development services, including biostatistics, statistical programming, medical writing, clinical monitoring, project management and data management, for a single study or an entire clinical program. The company has operations in San Bruno, Calif., in addition to Southborough.
WBJ Web Partners
Most Recent
Most Recent
0 Comments